口服乳托费林-响应性配方在IBD治疗的炎症性肠道区域周围固定
Jinfan Yang1,2, Ning Shang1,2, Zhengqing Li1,2
1College of Bioresources Chemical and Materials Engineering, Shaanxi University of Science & Technology, Xi'an, Shaanxi, 710021, China.
Advanced healthcare materials
|December 25, 2024
概括
一种新的口服配方改善了炎症性肠病 (IBD) 的治疗方法,通过使用对乳酸 (LF) 敏感的花,精确地将阿斯丁 (Ast) 输送到炎症区域,提高药物保留和治疗结果.
科学领域:
- 胃肠病学 胃肠病学
- 材料科学 材料科学 材料科学
- 药物输送系统 药物输送系统
背景情况:
- 口服配方是炎症性肠病 (IBD) 治疗的理想选择.
- 粘膜损伤和腹限制了IBD的药物保留和疗效.
- 开发有针对性的药物输送系统对于改善IBD治疗至关重要.
研究的目的:
- 开发一种精确的口服配方,用于阿斯丁 (Ast) 在IBD治疗中.
- 为了增强Ast的溶解性和在炎症部位的保留.
- 调查新型配方的治疗疗效和潜在机制.
主要方法:
- 开发一种口服阿斯塔山丁 (Ast) 配方,利用对乳酸铁素 (LF) 敏感的花.
- 评估原材料的Ast可溶性和安全性.
- 在IBD模型中体内评估配方的疗效,包括结肠长度和存活率.
- 对治疗机制的分析,重点是免疫调节,上皮细胞修复和肠道微生物群.
主要成果:
- 这种对LF敏感的配方在炎症区域周围实现了选择性的Ast定.
- 提高Ast的表面溶解度,降低安全风险.
- 在体内显著增加结肠长度和100%的生存率.
- 治疗机制包括改善免疫调节,上皮修复和肠道微生物群重塑.
结论:
- 开发的口服配方能够准确地输送AST用于IBD治疗.
- 对LF响应的花是一种有效的策略,可以增强药物保留和疗效.
- 这种方法为设计IBD的先进药物输送系统提供了一个有价值的平台.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
01:21Drugs for Treatment of Constipation-Predominant IBS
133
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
133
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
115
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
115
01:29Inflammatory Bowel Disease IV: Pharmacological Management
111
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
111
01:29Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95